Shanghai Changhai Hospital Clinical Research Ward
Shanghai, Shanghai Municipality, 200433, China
Location status: Recruiting
NCT Number: NCT06655051
The goal of this clinical trial is to compare the efficacy and safety of a single plastic stent versus a fully covered self-expanded metal stent in relieving benign biliary stricture secondary to chronic pancreatitis. The main questions it aims to answer is:
Whether the efficacy of a single plastic stent is non-inferior to that of a fully covered metal stent in patients with benign biliary stricture secondary to chronic pancreatitis?
Participants will be randomly assigned to receive either a single plastic stent (SPS) placement or fully covered self-expanded metal stent placement treatment for 6 months, and they will be followed up for 18 months.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Shanghai, Shanghai Municipality, 200433, China
Location status: Recruiting
Although a number of previous studies have shown that the drainage and dilation effect of a single plastic stent is limited for benign biliary stricture (BBS) secondary to chronic pancreatitis (CP), the poor management of CP itself in most studies may explain the unsatisfactory efficacy of a single biliary plastic stent in relieving CP secondary BBS. Investigators believe that the effective management of CP is an important step to solve the BBS secondary to CP, especially the effective removal of pancreatic duct stones, the relief of pancreatic duct obstruction and the maintenance of pancreatic duct patency. Previous data showed that in CP patients treated with ESWL combined with ERCP, 72.4% could achieve complete removal of main pancreatic duct stones and 90.8% could achieve successful endoscopic decompression. Under the premise of effectively removing the stones of the main pancreatic duct at the head of the pancreas and maintaining the patency of the pancreatic duct, using a single plastic stent for stent drainage of BBS is effective, and a single plastic stent has potential advantages such as lower stent displacement rate and cheaper. Therefore, investigators design a single-center, prospective, open-label, randomized controlled, non-inferiority trial to compare the effectiveness, safety, and cost-effectiveness of a single plastic stent and fcSEMS for the removal of CP secondary BBS under the premise that the primary disease, i.e. CP itself, was effectively managed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will undergo ERCP. A flexible tube is inserted into the duodenum, crossing the sphincter of Oddi to access the biliary system. And the location, diameter, and length of biliary stricture will be evaluated by injection of contrast media. A single plastic stent is then placed across the biliary stricture, allowing the bile duct to resume drainage. The participants will be observed closely after ERCP and record complications. Imaging evaluation will be conducted 6 months after stenting to confirm spontaneous passage of the biliary duct stent, and the stent will be removed via ERCP if it is still in place.
Participants will undergo ERCP. A flexible tube is inserted into the duodenum, crossing the sphincter of Oddi to access the biliary system. And the location, diameter, and length of biliary stricture will be evaluated by injection of contrast media. A fully covered self-expanding metal stent is then placed across the biliary stricture, allowing the bile duct to resume drainage. The participants will be observed closely after ERCP and record complications. Imaging evaluation will be conducted 6 months after stenting to confirm spontaneous passage of the biliary duct stent, and the stent will be removed via ERCP if it is still in place.
Time frame: 2 years after enrollment
Stricture resolution assessed at the time of final stent removal as well as the absence of objective findings of stricture recurrence during the 18 months, post-stenting follow-up period.
Time frame: 6 months after enrollment
Stricture resolution at the time all stent is removed. If there is a persistent stricture after 6 months of stent therapy in either group, the patient will be classified as a clinical failure.
Time frame: 6 months after enrollment
The completion of the initial and each follow-up ERCP, including stent deployment and removal.
Time frame: 2 years after enrollment
Device or procedure related adverse events from the initial stent placement procedure to the 2 year follow-up.
Time frame: 6 months after enrollment
Length of stent placement procedures and stent removal procedures.
Time frame: 6 months after enrollment
The number of endoscopic retrograde cholangiopancreatography (ERCP) procedures after initial stent placement.
Time frame: 6 months after enrollment
The total number of stents placed
Contact information is provided by the study sponsor or research team.
Lianghao Hu, M.D.
CONTACT
Zhaoshen Li, M.D.
CONTACT
Changhai Hospital
Other
Efficacy and Safety of Single Plastic Stent Compared With Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancreatitis: A Single Center,Prospective,Non-inferiority, Open Label, Randomized, Controlled Trial
Acronym: ESSENCE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06386224
Acute Recurrent Pancreatitis, Chronic Disease
Seattle, Washington, United States
View Trial DetailsNCT07707609
Agnosia, Chronic Disease
Hyderabad, Telangana, India
View Trial DetailsNCT07696572
Biliary Obstruction, Chronic Disease
Orlando, Florida, United States
View Trial DetailsNCT07285863
Chronic Disease, Chronic Pancreatitis
Rochester, Minnesota, United States
View Trial Details